Debt-free stocks represent companies with little to no debt on their balance sheets, making them financially stable and less vulnerable to interest rate fluctuations or economic downturns. These companies often rely on internal accruals to fund growth, reflecting strong cash flow management and operational efficiency.
For investors, debt-free stocks can offer a lower-risk option with consistent returns, especially in uncertain market conditions. They are often favoured for their resilience, sound fundamentals, and long-term wealth-building potential.
Following are a few little to no debt stocks with high net profit growth of up to 800 percent YoY:
1. Garden Reach Shipbuilders & Engineers Limited
With a market cap of Rs. 37,653 crores, the stock moved up by around 5 percent on BSE to close in the green at Rs. 3,286.95 on Friday.
In Q4 FY25, GRSE reported around 118 percent YoY growth in its net profit to Rs. 244 crores from Rs. 112 crores in Q4 FY24. Further, the company reported a PAT of Rs. 527 crores, growing at a 3-year CAGR of around 40 percent between FY22 and FY25.
GRSE is mainly engaged in the construction of warships. The Company was taken over by the Government of India in 1960. GRSE aims to become a Navratna company by 2030 and be globally recognised as the best Indian Shipyard company.
2. Shilchar Technologies Limited
With a market cap of Rs. 6,029.4 crores, the stock moved up by around 2 percent on BSE to close in the green at Rs. 5,270.35 on Friday.
In Q4 FY25, Shilchar Tech reported around 120 percent YoY growth in its net profit to Rs. 55 crores from Rs. 25 crores in Q4 FY24. Further, the company reported a PAT of Rs. 147 crores, growing at a 3-year CAGR of around 119 percent between FY22 and FY25.
Shilchar Technologies Limited is engaged in the business of manufacturing “distribution & power transformers” as well as “electronics & telecommunication transformers.”
3. RPG Life Sciences Limited
With a market cap of Rs. 3,893.4 crores, the stock moved down by around 2.6 percent on BSE to close in the red at Rs. 2,354.05 on Friday.
In Q4 FY25, RPG Life Sciences reported around 800 percent YoY growth in its net profit to Rs. 117 crores from Rs. 13 crores in Q4 FY24. Further, the company reported a PAT of Rs. 183 crores, growing at a 3-year CAGR of around 53 percent between FY22 and FY25.
RPG Life Sciences Limited is engaged in the business of manufacturing and marketing Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
